FDA panel soundly rejects Pfizer booster vaccinations except for those most at risk

An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe disease.

Related posts